IAK
iShares U.S. Insurance ETF
The iShares U.S. Insurance ETF seeks to track the investment results of an index composed of U.S. equities in the insurance sector.
US
EQUITY
Passive
MANAGEMENT STYLE
507.9 M
ASSETS UNDER MGMT
40 bp
EXPENSES
Fund Basics
| Fund sponsor | Barclays Global Fund Advisors |
| Category | US |
| Asset class | Equity |
| Website | link... |
| Inception date | May 01, 2006 |
| Assets (mns) | $508 |
| Expense ratio | 40 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Quarterly |
| Taxation | 1099 |
| Stock selection | Market Cap |
| Weighting | Market Cap |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| PROGRESSIVE CORP | 14.7 % |
| CHUBB LIMITED | 12.0 % |
| TRAVELERS COS INC/THE | 7.2 % |
| ALLSTATE CORP | 6.1 % |
| AFLAC INC | 4.6 % |
| HARTFORD FINANCIAL SVCS GRP | 4.4 % |
| PRUDENTIAL FINANCIAL INC | 4.3 % |
| AMERICAN INTERNATIONAL GROUP | 4.3 % |
| METLIFE INC | 4.2 % |
| ARCH CAPITAL GROUP LTD | 4.0 % |
Constituent Breakdown
| Number of holdings | 56 |
| Herfindahl-Hirschman Index | 613 |
| Wgt avg mkt cap (mns) | $54,762 |
| Large cap (>$10bn) | 86.3% |
| Mid cap ($2-10bn) | 12.1% |
| Small cap (<$2bn) | 1.6% |
| Developed mkts. | 100.0% |
| Emerging mkts. | 0.0% |
Country Exposure
 |
UNITED STATES | 82.6 % |
 |
SWITZERLAND | 12.0 % |
 |
BERMUDA | 5.4 % |
Historical Performance
Standardized Performance (as of 11/30/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 6.5% | -2.5% | 16.3% | 12.6% | 16.0% | 9.8% | -- | 5.2% |
| Dividend Yield | 0.4% | 0.4% | 1.0% | 1.3% | 1.8% | 2.0% | -- | 1.8% |
| Total Returns | 6.9% | -2.1% | 17.4% | 13.9% | 17.8% | 11.7% | -- | 6.9% | Ann. Volatility | 19.8% | 19.6% | 17.4% | 17.4% | 18.5% | 21.1% | -- | 26.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.53 | 28% |
| MSCI EAFE | 0.67 | 32% |
| MSCI Emg Mkts | 0.38 | 11% |
Liquidity Measures
| Avg. volume (000) | 108 |
| ADV traded (mns) | $14 |
| Turnover | 2.8% |
| Avg. Bid/Ask (% of price) | 0.09% |
Technical Indicators
| 30d moving avg. (EMA) | $131.76 |
| Relative strength (RSI) | 57 |
| MACD/Signal | 1.24/0.87 |
| Bollinger Bands (Upper/Lower) | $136.95/$126.37 |
| Short interest (% of AUM) | 0.5% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IAK |
Expenses vs. IAK |
ALTAR Score™ vs. IAK |
|---|---|---|---|---|
| KBWP | Invesco KBW Property & Casualty Insurance ETF | 53.7% | -5 bp | +7.1% |
| KIE | State Street SPDR S&P Insurance ETF | 48.7% | -5 bp | +7.0% |
| FXO | First Trust Financials AlphaDEX Fund | 23.3% | +22 bp | +8.3% |
| RSPF | Invesco S&P 500 Equal Weight Financials ETF | 22.5% | 0 bp | +6.8% |
| USCF | Themes US Cash Flow Champions ETF | 14.1% | -11 bp | +8.7% |
| IYF | iShares U.S. Financials ETF | 13.8% | 0 bp | +6.1% |
| LYLD | Cambria Large Cap Shareholder Yield ETF | 12.9% | +19 bp | +9.8% |
| LGCF | Themes US Cash Flow Champions ETF | 12.4% | -10 bp | +8.1% |
| AVIE | Avantis Inflation Focused Equity ETF | 12.1% | -15 bp | +7.0% |
| WTV | WisdomTree US Value Fund of Benef Interest | 12.0% | -28 bp | +8.9% |
Risk and Returns: IAK vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2024 | 2025 | 2026 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 12/2/2025
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
OVERWEIGHT
Above average appreciation potential. A rating of OVERWEIGHT is assigned to ETFs with ALTAR Scores in the 4th quintile (ranking higher than 60%-80%) of their category. Typically, funds in this category consist of stocks trading at attractive valuations and/or having above-average fundamentals.
ALTAR Score™
IAK
7.3%
Cat. Avg
5.7%
ALTAR Score™ Calculation
Category Overview
There are 1012 funds in the US Equity category, with an average ALTAR Score™
of 5.7% and a standard deviation of
2.3%. IAK's ALTAR Score™ is approximately
0.7 standard deviations
above
the category average. This places IAK in the 76th percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
IAKSELL
U/W
HOLD
O/W
BUY